The role of L1 in the progression of ovarian carcinomas

Zentralblatt fur Gynakologie

Volumn 126, Issue 5, 2004, Pages 323-325

  Altevogt, Peter ^a   Fogel, M ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

ADAM10; Cell migration; L1; Ovarian and endometrial carcinoma; Shedding

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; METALLOPROTEINASE ADAM 10; PROTEIN L1; UNCLASSIFIED DRUG;

APOPTOSIS; ASCITES; CANCER GROWTH; CELL ADHESION; CELL MIGRATION; ENDOMETRIUM TUMOR; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; NERVOUS SYSTEM DEVELOPMENT; OVARY CARCINOMA; OVARY TUMOR; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW;

DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 6344269172     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832304     Document Type: Review

References (9)

1. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, BenArie A, Huszar M, Altevogt P. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 2003; 362: 869-875
2. Beer S, Oleszewski M, Gutwein P, Geiger C, Altevogt P. Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. J Cell Sci 1999; 112: 2667-2675
3. Schlöndorff J, Blobel CP. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci 1999; 112: 3603-3617
4. Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V, Altevogt P. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001; 155: 661-674
5. Debiec H, Christensen EI, Ronco PM. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. J Cell Biol 1998; 143: 2067-2079
6. DiSciullo G, Donahue T, Schachner M, Bogen SA. L1 antibodies block lymph node fibroblastic reticular matrix remodeling in vivo. J Exp Med 1998; 187: 1953-1963
7. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M, Altevogt P. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. Faseb J 2003; 17: 292-294
8. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. ERK-regulated gene expression contributes to L1-CAM dependent motility and invasion. J Biol Chem 2004; 28880-28888
9. Primiano T, Baig M, Maliyekkel A, Chang BD, Fellars S, Sadhu J, Axenovich SA, Holzmayer TA, Roninson IB. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell 2003; 4: 41-53